Biotech · Private company
ImCheck Therapeutics, an Ipsen company
Track this companyFree. Adds ImCheck Therapeutics, an Ipsen company to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- IV ICT01Phase 2 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- First-in-Human Study of ICT01 in Patients With Advanced CancerPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Mar 5, 2020ClinicalTrials.gov NCT04243499 · fetched Nov 12, 2026